DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease – a multicentre RCT

被引：0

作者：

Rob Jones

Bart Sheehan

Patrick Phillips

Ed Juszczak

Jessica Adams

Ashley Baldwin

Clive Ballard

Sube Banerjee

Bob Barber

Peter Bentham

Richard Brown

Alistair Burns

Tom Dening

David Findlay

Richard Gray

Mary Griffin

Clive Holmes

Alan Hughes

Robin Jacoby

Tony Johnson

Roy Jones

Martin Knapp

James Lindesay

Ian McKeith

Rupert McShane

Ajay Macharouthu

John O'Brien

Caroline Onions

Peter Passmore

James Raftery

Craig Ritchie

Rob Howard

机构：

[1] The University of Nottingham,Section of Old Age Psychiatry

[2] A Floor,Health Sciences Research Institute, Warwick Medical School

[3] South Block,Head of NHS Statistical Support Team, Centre for Statistics in Medicine, Wolfson College Annexe

[4] Queen's Medical Centre,Knowlsey Resource & Recover Centre

[5] University of Warwick,Wolfson Centre for Age Related Disease, Guy's Campus

[6] MRC Clinical Trials Unit,PO26, Section of Mental Health and Ageing, Health Services Research Department, The David Goldberg Centre

[7] University of Oxford,Institute for Ageing and Health

[8] Institute of Psychiatry,Department of Psychiatry

[9] Whiston Hospital,Education and Research Centre, School of Psychiatry and Behavioural Sciences

[10] King's College,Older People's Mental Health Service

[11] The Institute of Psychiatry,Dundee Community Health Partnership, Gowrie House

[12] University of Newcastle,Department of Old Age Psychiatry

[13] Wolfson Research Centre,Department of Geriatric Psychiatry

[14] Newcastle General Hospital,University of Oxford, Department of Psychiatry

[15] Queen Elizabeth Psychiatric Hospital,MRC Biostatistics Unit (& MRC Clinical Trials Unit, London)

[16] Kings College London,Research Institute for Care of the Elderly

[17] Institute of Psychiatry,Department of Economics of Mental Health

[18] Wythenshawe Hospital,Department of Health Sciences

[19] Fulbourn Hospital,Old Age Psychiatry

[20] Royal Dundee Liff Hospital,The Fulbrook Centre

[21] University of Birmingham,Wolfson Research Centre

[22] PO70 Institute of Psychiatry,School of Medicine

[23] Moorgreen Hospital,undefined

[24] Inverclyde Royal Hospital,undefined

[25] The Warneford Hospital,undefined

[26] Institute of Public Health,undefined

[27] University Forvie Site,undefined

[28] St Martin's Hospital,undefined

[29] Kings College London,undefined

[30] Institute of Psychiatry,undefined

[31] University of Leicester,undefined

[32] Leicester General Hospital,undefined

[33] University of Newcastle,undefined

[34] Wolfson Research Centre,undefined

[35] Newcastle General Hospital,undefined

[36] The Churchill Hospital,undefined

[37] North West Kilmarnock Area centre,undefined

[38] Newcastle General Hospital,undefined

[39] PO70 Institute of Psychiatry,undefined

[40] Whitla Medical Building,undefined

[41] University of Southampton,undefined

[42] Charing Cross Hospital,undefined

[43] Claybrook Centre,undefined

[44] PO70,undefined

[45] Institute of Psychiatry,undefined

来源：

Trials | / 10卷

关键词：

Memantine; Cholinesterase Inhibitor; Rivastigmine; MMSE Score; Galantamine;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT
Jones, Rob
Sheehan, Bart
Phillips, Patrick
Juszczak, Ed
Adams, Jessica
Baldwin, Ashley
Ballard, Clive
Banerjee, Sube
Barber, Bob
Bentham, Peter
Brown, Richard
Burns, Alistair
Dening, Tom
Findlay, David
Gray, Richard
Griffin, Mary
Holmes, Clive
Hughes, Alan
Jacoby, Robin
Johnson, Tony
Jones, Roy
Knapp, Martin
Lindesay, James
McKeith, Ian
McShane, Rupert
Macharouthu, Ajay
O'Brien, John
Onions, Caroline
Passmore, Peter
Raftery, James
Ritchie, Craig
Howard, Rob
[J]. TRIALS, 2009, 10
[2] Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial)
Knapp, Martin
King, Derek
Romeo, Renee
Adams, Jessica
Baldwin, Ashley
Ballard, Clive
Banerjee, Sube
Barber, Robert
Bentham, Peter
Brown, Richard G.
Burns, Alistair
Dening, Tom
Findlay, David
Holmes, Clive
Johnson, Tony
Jones, Robert
Katona, Cornelius
Lindesay, James
Macharouthu, Ajay
McKeith, Ian
McShane, Rupert
O'Brien, John T.
Phillips, Patrick P. J.
Sheehan, Bart
Howard, Robert
[J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2017, 32 (12) : 1205 - 1216
[3] Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses
Howard, Robert
McShane, Rupert
Lindesay, James
Ritchie, Craig
Baldwin, Ashley
Barber, Robert
Burns, Alistair
Dening, Tom
Findlay, David
Holmes, Clive
Jones, Robert
Jones, Roy
McKeith, Ian
Macharouthu, Ajay
O'Brien, John
Sheehan, Bart
Juszczak, Edmund
Katona, Cornelius
Hills, Robert
Knapp, Martin
Ballard, Clive
Brown, Richard G.
Banerjee, Sube
Adams, Jessica
Johnson, Tony
Bentham, Peter
Phillips, Patrick P. J.
[J]. LANCET NEUROLOGY, 2015, 14 (12): : 1171 - 1181
[4] Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
Howard, Robert
McShane, Rupert
Lindesay, James
Ritchie, Craig
Baldwin, Ashley
Barber, Robert
Burns, Alistair
Dening, Tom
Findlay, David
Holmes, Clive
Hughes, Alan
Jacoby, Robin
Jones, Rob
Jones, Roy
McKeith, Ian
Macharouthu, Ajay
O'Brien, John
Passmore, Peter
Sheehan, Bart
Juszczak, Edmund
Katona, Cornelius
Hills, Robert
Knapp, Martin
Ballard, Clive
Brown, Richard
Banerjee, Sube
Onions, Caroline
Griffin, Mary
Adams, Jessica
Gray, Richard
Johnson, Tony
Bentham, Peter
Phillips, Patrick
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (10): : 893 - 903
[5] Memantine/donepezil dual therapy is superior to placebo/donepezil therapy for treatment of moderate to severe Alzheimer's disease
Tariot, PN
Farlow, MR
Grossberg, G
Gergel, I
Graham, S
Jin, J
[J]. INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 289 - 289
[6] Memantine in moderate to severe Alzheimer’s disease
Andrew Kertesz
[J]. Current Neurology and Neuroscience Reports, 2003, 3 (6) : 485 - 486
[7] Memantine enhances autonomy in moderate to severe Alzheimer's disease patients already receiving donepezil
Wirth, Y.
Rive, B.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 474 - 474
[8] Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease
Waldemar, G.
Hyvarinen, M.
Wetterberg, P.
Korner, A.
Lehto, H.
Josiassen, M. K.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 188 - 188
[9] Effects of donepezil in patients with moderate-to-severe Alzheimer's disease discontinuing memantine monotherapy
Sakka, P.
Tsolaki, M.
Hort, J.
Hager, K.
Soininen, H.
Lopez-Pousa, S.
Li, C.
Schwam, E.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 58 - 58
[10] Effect of memantine treatment at patients with moderate-severe Alzheimer's disease treated with Donepezil
Szalontay, A. S.
Chirita, R.
Chirita, V.
[J]. EUROPEAN PSYCHIATRY, 2008, 23 : S198 - S198

← 1 2 3 4 5 →